ARTICLE | Clinical News

Trans Sodium Crocetinate: Phase I/II data

December 6, 2010 8:00 AM UTC

A double-blind, dose-escalation, U.S. Phase I/II trial in 48 patients showed that once-daily 1.5 mg/kg IV TSC for 5 days improved PWT on a graded treadmill test by nearly 3 times more than the improve...